TrialJournal of clinical oncology : official journal of the American Society of Clinical Oncology2021

Gemcitabine Plus Cisplatin Versus Fluorouracil Plus Cisplatin as First-Line Therapy for Recurrent or Metastatic Nasopharyngeal Carcinoma: Final Overall Survival Analysis of GEM20110714 Phase III Study.

Shaodong Hong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.